I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 6 studies | 32% ± 9% | |
| natural killer cell | 6 studies | 21% ± 3% | |
| endothelial cell | 5 studies | 24% ± 8% | |
| CD8-positive, alpha-beta T cell | 5 studies | 19% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 19% ± 4% | |
| CD4-positive, alpha-beta T cell | 4 studies | 24% ± 3% | |
| epithelial cell | 4 studies | 42% ± 15% | |
| retina horizontal cell | 4 studies | 26% ± 4% | |
| plasmacytoid dendritic cell | 4 studies | 23% ± 6% | |
| conventional dendritic cell | 3 studies | 28% ± 13% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 16% ± 1% | |
| hematopoietic precursor cell | 3 studies | 22% ± 7% | |
| non-classical monocyte | 3 studies | 19% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 18% ± 2% | |
| effector CD8-positive, alpha-beta T cell | 3 studies | 17% ± 3% | |
| macrophage | 3 studies | 21% ± 2% | |
| GABAergic neuron | 3 studies | 37% ± 4% | |
| glutamatergic neuron | 3 studies | 46% ± 8% | |
| dendritic cell | 3 studies | 27% ± 7% | |
| gamma-delta T cell | 3 studies | 29% ± 16% | |
| regulatory T cell | 3 studies | 20% ± 2% |
